LIGAND PHARMACEUTICALS INCORPORATED Increase (Decrease) in Intangible Assets, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Increase (Decrease) in Intangible Assets, Current of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in intangible assets, current for fiscal 2025 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in intangible assets, current for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in intangible assets, current for fiscal 2023 was $5.00M.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in intangible assets, current for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Intangible Assets, Current 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-27 |
| 2023-12-31 | $5.00M 10-K · filed 2026-02-27 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |